Daewoong Pharmaceutical’s ‘Anplone SR Tab’ wipes the market only in 3 years

Published: 2018-01-29 12:39:31

Updated: 2018-01-29 12:39:31

Daewoong Pharmaceutical’s ‘Anplone SR Tab’ has become the leading product in the sarpogrelate release-type drug market in 3 years of its launch.

According to Daewoong Pharmaceutical, Anplone SR Tab was ranked the top in the sarpogrelate release-type drug market as recording KRW 12.2 billion outpatient prescriptions in 2017.

Launched in 2015, Anplone SR Tab showed a potential to become a block...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.